MEFV and familial Mediterranean fever: Colchicine has been found to have a significant therapeutic effect on patients with FMF, and a hypothesis posits that FMF mutations lower the threshold for pyrin inflammasome activation, necessitating simultaneous mutations at both sites to cause the disease.